Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2010
05/26/2010CN1553814B Remedies for arteriosclerosis
05/26/2010CN101715453A heterocyclic compounds and their uses
05/26/2010CN101712683A Poly-nitrohexaazaisowurtzitane derivatives and synthesis methods thereof
05/26/2010CN101712585A Organic-matter nitrosoation method with no production of nitric oxide waste gas
05/25/2010US7723530 Used in electrooptical systems such as TV screens, liquid crystal displays, charge coupled devices, plasma displays or electroluminescent displays; do not tend to aggregate, show very good dispersibility; high transparence and pure hue
05/25/2010US7723374 3-[5-ethoxy-1-(4-ethyl-benzenesulfonyl)-1H-indol-3-yl]-propionic acid for example; obesity, diabetes, syndrome X, breast or thyroid cancer, inflammatory skin disorders such as psoriasis, cardiovascular disorders, eating disorders such as bulimia; peroxisome proliferator-activated receptors (PPAR) agonist
05/25/2010US7723367 Amino-tetrazoles analogues and methods of use
05/25/2010US7723337 3-cinnolinecarboxamide derivatives and their use for treating cancer
05/25/2010US7723336 Fused heterocyclic compounds useful as kinase modulators
05/25/2010US7723330 Heterobicyclic pyrazole compounds and methods of use
05/25/2010US7723323 fused 1,2,4-triazoles for modulating the activity of 11 beta -hydroxysteroid dehydrogenase type 1 (11 beta HSD1) and the use of these compounds as pharmaceutical compositions has been described. Also a novel class of fused 1,2,4-triazoles, their use in therapy, pharmaceutical compositions
05/25/2010US7723322 that can trap isotopic fluorine so that when the biological molecule accumulates in the desired type of cell, the isotopic fluorine is imaged by PET scan
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/25/2010CA2462922C Reverse-turn mimetics and method relating thereto
05/25/2010CA2248303C Perfluorinated amide salts and their uses as ionic conducting materials
05/20/2010WO2010057104A2 Pyridoindole modulators of nmda receptor and acetylcholinesterase
05/20/2010WO2010056999A1 Enantiomerically enriched aryloazol- 2 -yl cyanoethylamino paraciticidal compounds
05/20/2010WO2010056875A1 Pyridazinones and their use as btk inhibitors
05/20/2010WO2010056708A1 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
05/20/2010WO2010056656A2 Preparation of crystalline palonosetron hydrochloride
05/20/2010WO2010056644A1 1- (ARYLSULFONYL) -4- (PI PERAZIN-I -YL) -IH-BENZ IMIDAZOLES AS δ-HYDROXYTRYPTAMINE- 6 LIGANDS
05/20/2010WO2010056631A1 Inhibitors of fatty acid binding protein (fabp)
05/20/2010WO2010056320A2 Pi3k/mtor kinase inhibitors
05/20/2010WO2010056038A2 Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
05/20/2010WO2010055006A1 Naphthylacetic acids used as crth2 antagonists or partial agonists
05/20/2010WO2010054961A1 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
05/20/2010WO2010054763A1 Heterocyclically substituted aryl compounds as hif inhibitors
05/20/2010US20100125136 Porphyrin-based photosensitizer dyes for dye-sensitized solar cells
05/20/2010US20100125074 Thieno-[2,3-d]Pyrimidine and Thieno-Pyridazine Compounds and Methods of Use
05/20/2010US20100125068 Methods for inhibiting protein kinases
05/20/2010US20100125066 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
05/20/2010US20100124544 Crystalline forms of dihydropyrazolopyrimidinone
05/20/2010CA2743715A1 Enantiomerically enriched aryloazol-2-yl cyanoethylamino paraciticidal compounds
05/20/2010CA2743449A1 Pyrazinopyrazines and derivatives as kinase inhibitors
05/20/2010CA2743299A1 Inhibitors of fatty acid binding protein (fabp)
05/20/2010CA2743257A1 Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
05/20/2010CA2743015A1 Pi3k/mtor kinase inhibitors
05/20/2010CA2742783A1 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
05/20/2010CA2741018A1 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
05/20/2010CA2740262A1 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
05/20/2010CA2739725A1 Naphthylacetic acids used as crth2 antagonists or partial agonists
05/19/2010EP2186813A1 Condensed N-heterocyclic compounds and their use as CRF receptor antagonists
05/19/2010EP2185562A1 Pyrrolopyrimidines
05/19/2010EP2185561A2 1,2,3,4-tetrahydropyrroloý1,2-a¨pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrroloý1,2-a¨ý1,4¨-diazépine-7-carboxamide derivatives, preparation and therapeutic use thereof
05/19/2010EP2185555A1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
05/19/2010EP2185549A1 Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
05/19/2010EP2185522A1 Gamma secretase modulators
05/19/2010EP1485380B1 Azolylaminoazines as inhibitors of protein kinases
05/19/2010EP1467995B1 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
05/19/2010CN101066945B Process of synthesizing 3-substituted lactan compound
05/18/2010US7718794 Synthesis of porphyrins designed for attachment to electroactive surfaces via one or more carbon tethers
05/18/2010US7718706 pesticides and/or herbicides for controlling pests in crop protection, in the domestic sector, in the hygiene sector and in the protection of stored products
05/18/2010US7718670 antagonists of M3 muscarinic receptors; N-(1-Azabicyclo[2.2.2]oct-3-yl)-2-hydroxy-2,2-dithien-2-ylacetamide; respiratory disorders, urological disorders, gastrointestinal disorders, cardiovascular disorders; reaction with organometallic derivative
05/18/2010US7718666 Pyrido [2,1-a] isoquinoline derivatives
05/18/2010US7718662 Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase
05/18/2010US7718660 Inhibitors of folic acid-dependent enzymes
05/18/2010US7718650 Piperazino or diazepino-substituted arylsulfonamides; obesity, type II diabetes and/or central nervous system disorders; 4-chloro-N-[5-(4-methyl-1,4-diazepan-1-yl)-2-nitrophenyl]benzenesulfonamide for example; Serotonin 5-HT6 receptor antagonist activity
05/18/2010US7718648 Pyridobenzazepine compounds and methods for inhibiting mitotic progression
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2437754C Tablets quickly disintegrated in oral cavity
05/18/2010CA2430508C Condensed purine derivatives as a1 adenosine receptor antagonists
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2131797C Condensed indole derivatives as 5ht4-receptor antagonists
05/14/2010WO2010054260A1 Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases
05/14/2010WO2010054114A2 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
05/14/2010WO2010054113A2 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
05/14/2010WO2010054067A1 Gamma secretase modulators
05/14/2010WO2010053825A1 2-aminopyrimidine compounds as serotonin receptor modulators
05/14/2010WO2010053583A2 Small molecule cd4 mimetics and uses thereof
05/14/2010WO2010052732A1 Cinnamido-pvrrolor[2,1-c][1,4]benzodiazepines as potential anticancer agents and process for the preparation thereof
05/14/2010WO2010052475A1 Process for resolving zopiclone
05/14/2010WO2010017093A3 Dopamine receptor ligands with enhanced duration of action
05/14/2010WO2010014798A3 Pyrimidotriazinediones and pyrimidopyrimidinediones and methods of using the same
05/14/2010WO2010014739A3 Heterocyclic modulators of tgr5
05/14/2010WO2010012781A3 New crystalline salt forms of a 5,6,7,8-tetrahydro-1,2,4- triazolo[4,3-a]pyrazine derivative
05/14/2010WO2010011658A3 Pyromellitic diimide organic semiconductors and devices
05/14/2010WO2009134616A8 Novel inhibitors of hepatitis c virus replication
05/14/2010WO2009097515A3 [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
05/14/2010CA2742725A1 Process for resolving zopiclone
05/14/2010CA2742602A1 Gamma secretase modulators
05/13/2010US20100121255 Compound
05/13/2010US20100121055 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
05/13/2010US20100121053 Method For Directly Producing Fine-Particle Diketopyrrolopyrrol Pigments
05/13/2010US20100121050 Processes for making zilpaterol and salts thereof
05/13/2010US20100120863 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
05/13/2010US20100120801 Akt and p70 s6 kinase inhibitors
05/13/2010US20100120781 Novel Compounds for Treatment of Cancer and Disorders Associated with Angiogenesis Function
05/13/2010US20100120774 (2R,3 S)-3 ((2-chloro-4-pyrimidinyl)amino)-4-(3,5-difluorophenyl)-1 (((4'S)-6'-(2,2-dimethylpropyl)-3', 4'-dihydrospiro[cyclobutane-1,2'-pyrano[2,3-b]pyridin]-4'-yl)amino)-2-butanol, used for the treatment Alzheimer's disease, cognitive deficits and impairment, and schizophrenia
05/13/2010US20100120763 Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases
05/13/2010US20100120762 Triazine derivatives as inhibitors of phosphodiesterases
05/13/2010US20100120761 Bicyclic Heterocyclic Compounds as FGFR Inhibitors
05/13/2010US20100120758 Reverse-turn mimetics and method relating thereto
05/13/2010US20100120751 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
05/13/2010US20100120741 Heterocyclic inhibitors of histamine receptors for the treatment of disease
05/13/2010US20100120739 Triazolopyridazine protein kinase modulators
05/13/2010US20100119966 Diketopyrrolopyrrole Cocrystals With High Transparency
05/12/2010EP2184272A1 Piperazine derivative
05/12/2010EP2183252A2 Compounds for the treatment of hepatitis c
05/12/2010EP2183243A2 Pyrazole compounds and their use as raf inhibitors
1 ... 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 ... 573